Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
10,935 total articles
Oscar Health rallied to a new multiple after guidance that points to an operating-profit inflection. The company is trading below 1x revenue with meaningful free cash flow, but the next leg of gains requires steady claims trends, disciplined underwriting and membership retention. This is a long-term trade idea: enter near current levels, cut losses…
Stifel Financial (SF) is trading below its recent highs on sentiment tied to cash-flow fears. Fundamentals - low leverage, solid free cash flow, and a reasonable P/E - argue the pullback is an entry opportunity. This trade idea lays out an explicit mid-term plan with entry, stop, and target.
Orchestra BioMed (OBIO) is approaching a binary moment: the first of two pivotal readouts for its AVIM and Virtue programs is expected in the coming months. The stock, trading at roughly $3.60 and with a market cap of about $217M, is small and volatile but offers asymmetric upside if clinical data beats expectations. This trade idea lays out an act…
Micron has rallied hard on fresh forecasts for rising memory prices and capacity discipline across the industry. Fundamentals - strong free cash flow, high ROE, and minimal leverage - back the rally. This trade idea outlines an actionable long with exact entry, stop and target, a mid-term time horizon (45 trading days), and balanced risk framing.
Aehr Test Systems (AEHR) has pivoted into AI processor testing and wafer-level burn-in where hyperscalers are struggling to secure validated parts. Strong bookings, a growing backlog and technical momentum create a time-boxed trade. This idea outlines an entry, stop and target for a mid-term (45 trading days) swing while calling out valuation, exec…
Carnival (CCL) is trading near $26 after a late-June guidance scare tied to fuel and geopolitical uncertainty. The headline risk is real - fuel and demand visibility have worsened - but the company reported a record revenue quarter ($6.66B) and generated $3.2B of free cash flow, with deposits at a record $9B and meaningful debt reduction. At ~12x e…
KeyCorp (KEY) looks attractively priced after management authorized a $3.0 billion buyback and continued to pay a healthy quarterly dividend. With a market cap near $24.8B, a P/E around 13.7 and P/B roughly 1.24, the stock offers upside if net interest income and fee lines keep improving. This trade idea outlines a mid-term (45 trading days) swing …
Ondas (ONDS) just reset the narrative: Q1 revenue shock, a $450M+ backlog, and two strategic acquisitions (Omnisys and Cyberhawk) that accelerate recurring revenue and margins. The market is focused on parabolic share moves; we see a rational risk/reward to own a tactical long over the next 45 trading days into Q3 catalysts. Entry $8.25, target $15…
Powell Industries (POWL) enters Q3 with a sizable backlog, clean balance sheet and strong cash flow. Valuation is rich but not out of line given recent order acceleration and no debt. This trade recommends buying into earnings with a clear stop and target on a mid-term horizon.
Fiserv has engineered its own near-term volatility through leadership churn and a debt reshuffle, but the stock now trades at roughly 8.4x trailing earnings with $4.13B of free cash flow. For event-driven, value-seeking traders, that combination creates a high-expected-value long: enter around $50.45, stop at $47.00, target $60.00 over a primary mi…
Travel + Leisure's mix of vacation-ownership sales, travel memberships and travel-tech exposure is generating cash and momentum. At $74.30, the stock offers a compelling risk-reward for a swing trade: strong FCF yield (~9.5%), a dividend, and upside to the $81 area if summer travel trends hold. Technicals and rising short interest add both opportun…
Autolus is transitioning from development-stage biotech to a commercial-stage company with AUCATZYL sales and a 2026 revenue guide of $120-135M. That puts a sub-$400M market cap against tangible product revenue and multiple upcoming clinical readouts. This is an asymmetric, event-driven long where upside is paired with outsized volatility — trade i…
Arrowhead Research Corporation's Redemplo SHTG readout cleared a high bar and the stock has ripped to a new 52-week high. The biotech now trades with elevated valuation and strong technical momentum. This trade idea lays out a mid-term (45 trading days) long with clear entry, stop and target while mapping catalysts and risks that could flip the the…
Duos Technologies (DUOT) has gone from niche rail-inspection tech to a small but fast-growing Edge AI infrastructure play. Recent contract wins and a $65M equity raise to scale modular Edge Data Centers underpin a long trade idea: enter at $8.49, stop at $6.50, target $14.00 over a long-term (180 trading days) horizon. This is a high-risk, high-rew…
Marvell (MRVL) is a leading provider of custom silicon, networking and optical connectivity for AI data centers. With a market cap near $190.5B, low leverage and positive cash flow, the company can grow into its valuation if hyperscalers continue shifting spend to networking and custom ASICs. This trade idea outlines a mid-term (45 trading days) ta…
Netflix remains a cash-generative leader in streaming despite recent share-price weakness. Record quarterly revenue, improving operating margins and a $11.15B free cash flow run-rate create a margin of safety at ~21x earnings. This trade plan targets $110 on a 180-trading-day horizon with a $60 stop to respect the company-specific downside.
Ioneer (IONR) remains a high-risk lithium/minerals play, but a $700M U.S. loan offer and favorable policy attention have meaningfully reduced project execution risk. The shares trade at a modest market cap ($262M) with technicals near oversold; this trade targets event-driven re-rating over the next 180 trading days while respecting commodity and p…
Taiwan Semiconductor Manufacturing Co. is printing outsized growth thanks to AI demand and is raising prices and capex. The market trimmed the stock after earnings, signaling skepticism about sustainability. We present a swing trade that leans with the secular AI story while limiting downside with a tight stop.
Roblox has a strong creator-driven flywheel and the balance sheet and free cash flow to invest in advanced creator tooling. Recent headwinds from age-verification and litigation have set expectations lower; that creates a trade entry now. If AI-enabled content creation and moderation drive higher engagement and monetization, RBLX should re-rate fro…
Nvidia remains the engine of modern AI infrastructure. Its dominant margins, massive free cash flow ($119.08B annual FCF) and near-zero net leverage create room for a steadily growing dividend and capital returns. For traders: a defined long with entry near $205, a protective stop under $195, and multi-horizon targets at $240 and $300 captures both…
Outdoor Holding has built a defensible operational footprint - category-focused retail, tight inventory turns, and supplier partnerships - that should drive margin expansion even if revenue growth remains modest. This trade targets EBITDA re-rating over the next 180 trading days with a clear entry, stop and target.
Ceragon Networks is facing cyclical softness and technical pressure, yet at roughly $2.28 the stock offers an asymmetric risk/reward. Low leverage, positive free cash flow, and sub-1x EV/Sales suggest a tactical long for informed traders. This idea lays out a mid-term (45 trading days) trade plan with concrete entry, target and stop-loss levels and…
Applied Optoelectronics (AAOI) has become a poster child for the AI-capex trade: strong order flow for optical transceivers has powered a >400% rally in 2026. Fundamentals show solid liquidity and low leverage, but the market is pricing a lot of perfection. This trade idea favors a controlled long with a clear stop and a 45-trading-day horizon to c…
Amphenol (APH) is a high-quality industrial growth compounder exposed to secular tailwinds in AI infrastructure, 5G and broadband. The shares trade at a premium but the company generates healthy free cash flow, industry-leading ROE and diversified end-market exposure. We upgrade to a buy (trade) and recommend a mid-term long with an entry at $157.5…
BioMarin's nine commercial therapies and strong free cash flow create a safety net that the market underappreciates. With positive VOXZOGO Phase 3 data and a clear path to an sNDA submission in Q3 2026, paired with a conservative balance sheet (about $2.8B cash) and $767M in free cash flow, BMRN looks positioned for a mid-term upside. This trade ta…
